Regenerative Medicine Advanced Therapy (RMAT) designation follows Phase Ib 36-month data Study demonstrated favorable safety profile and continued positive trends in assessed clinical outcome measures ...
Q4 2024 Earnings Call Transcript February 18, 2025 Axsome Therapeutics, Inc. misses on earnings expectations. Reported EPS is ...
Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced that it received a Refusal to File (RTF) letter from the U.S. Food and Drug Administration (FDA) for pitolisant for the treatment of ...
D Molecular Therapeutics is undervalued, with its lead candidate 4D-150 showing potential. Click here to find out why I rate ...
The newly launched OnePlus Watch 3 offers an ECG feature, but it won't be available to users in the US and Canada.
We remain optimistic about Australian healthcare investments, with key trials and FDA approvals expected in 2025, potentially ...
President Donald Trump recently issued two executive orders furthering his policy to reduce the number of federal regulations and the size of ...
The U.S. Food and Drug Administration has posted an update on a granola bar recall initiated last year, labeling it as “Class ...
The safety of breast implants has been controversial for decades. On February 6, 2025, the Food and Drug Administration ...
Consuming the recalled pretzels if you have a milk allergy could cause "serious adverse health consequences or death." ...
The U.S. Food and Drug Administration has made an update to its MadeGood granola bar recall. The popular granola bars, sold ...
The Food and Drug Administration (FDA) is warning consumers to not buy multiple types of granola bars. The bars were upgraded to class 2, which means consuming the granola could cause ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results